| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
1e-05 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
3e-05 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0003 |
| mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |